Following APC mutation, the progression of CRC involves a series of additional genetic changes, notably mutations in KRAS and TP53 involved in cell growth and differentiation and the loss of cell cycle control and increased mutation rates, respectively [3,4]. The gene discussed is KRAS; the disease is colorectal carcinoma.